Medtronic to invest $47.2M in cardiovascular device plant in Shanghai FTZ

Medtronic will invest about CNY300 million ($47.2 million) to build core cardiovascular device production lines in the Lingang Special Area of Shanghai's free trade zone. Construction is expected to start in June 2022 and wrap up within five years, with annual output capacity worth about CNY300 million in the third year of operation.

“Medtronic will spend about CNY300 million (USD47.2 million) on the project's initial phase.”yicaiglobal.com

• 1 source
• yicaiglobal.comMedtronic to Invest Millions in Core Heart Device Production in Shanghai FTZQian TongxinFeb 14, 2022

Summarized from public sources; check the original articles before acting on it.